Scale -

  • Revenue is 110 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 22 %
  • Quarterly Revenue is 32.99 Rs Cr; Continuous Growth over 3 Quarters
  • Ebitda is 17.06 Rs Cr; 5 Year CAGR is 25 %
  • PBT is 3.08 Rs Cr; 5 Year CAGR is 26 %; Annual Decline is -16 %
  • PAT is 13.12 Rs Cr; 5 Year CAGR is 26 %; Annual Decline is -19 %

Profitability -

  • PBDIT Margin is 15.45 %; in Top Quartile; Annual Decline is -16 %
  • PAT Margin is 11.88 %; in Top Quartile; Annual Decline is -24 %
  • Quarterly Ebitda Margin is 12 %; in Top Quartile; Continuous Decline over 3 Quarters

Return -

  • ROCE is 17.27 %; in Top Quartile; Annual Decline is -22 %
  • Asset Turnover is 96 %; in Top Quartile
  • ROA is 9.85 %; Annual Decline is -41 %
  • ROE is 14.18 %; Annual Decline is -32 %

Efficiency -

  • Current Ratio is 3.05; in Top Quartile; Annual Decline is -43 %
  • Quick Ratio is 0.52; Annual Decline is -47 %; Continuous Decline over 3 years; 5 Year CAGR is -28 %
  • Operating cash flow is -16.09 Rs Cr; Annual Decline is -1233 %

Solvancy -

  • Long term Debt is 0.95 Rs Cr; Annual Decline is -68 %; 5 Year CAGR is -27 %
  • Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %
  • Debt/Equity is 0.4; Annual Growth is 111 %
  • Total Debt is 37.03 Rs Cr; Annual Growth is 150 %; Continuous Growth over 3 years; 5 Year CAGR is 31 %

Quality -

  • Change in Inventories/Total Expenses is -30 %; Annual Decline is -41 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 12 %; Continuous Decline over 3 years
  • Operating cashflow/ebitda is -94 %; Annual Decline is -1370 %; in Bottom Quartile
  • Operating cashflow/PAT is -123 %; Annual Decline is -1505 %; in Bottom Quartile
  • Current Tax/PAT is 6 %; Annual Growth is 210 %
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Q2 Results, Oct 30: Reliance Industries, Jio Platforms, BEL, IOCL, Varun Beverages, Bank of Baroda, NTPC Green, others to post earnings
Read More
  • Past/current
Indo US Biotech Share Price Decline Analysis
Read More
  • Past/current
ICICI PRUDENTIAL NIFTY PHARMA ETF Stock/Share price , NSE/BSE Forecast News and Live Quotes
Read More
  • Past/current
Indo US Bio-Tech Ltd Locks at Upper Circuit With 17.13% Gain — Buyers Queue, Sellers Absent
Read More
  • Past/current
Indo US Bio-Tech Share Price and Technical Outlook
Read More
  • Past/current
Indo US Bio-Tech Upper Circuit Streak: Day 2 Price and Data
Read More
  • Past/current
Momentum Stocks: Onward Technologies, TBZ locked in lower circuits; Allied Blenders sheds 4%
Read More
  • Past/current
INDOUS Share Price Hits Upper Circuit on NSE
Read More
  • Past/current
Indo US Bio-Tech Ltd. Estimates – NSE:INDOUS
Read More
  • Past/current
Top 14 Pharma Stocks To Buy In India October 2026
Read More
  • Past/current
Indo US Bio-Tech Share Price News: Agri Stock Drops Today
Read More
  • Past/current
HD Fire Protect shares list at nearly 24% premium; here's how much investors made per lot
Read More
  • Past/current
Indo Us Bio Tech (NSE:INDOUS): What Does Its Q2 FY27 Reg 74(5) Certificate Confirm?
Read More
  • Past/current
Indo Us Biotech (INDOUS.NS) Edges 1.04% Lower to ?74.15, ?70.44 Support in Focus
Read More
  • Past/current
Indo US Biotech (INDOUS.NS) Trades Flat at ?75.53 as Market Watches ?79.31 Resistance
Read More
  • Past/current
Indo Us Bio Tech INDOUS 22nd AGM Voting Results
Read More
  • Past/current
Indo US Bio-Tech passes all five AGM resolutions including auditor appointment
Read More
  • Past/current
List of 5,818 AgriTech Startups in India & Market Trends (Oct 2026)
Read More
  • Past/current